Search results
Author(s):
Jaber Abboud
,
Joachim R Ehrlich
Added:
3 years ago
Implantable cardioverter defibrillators (ICDs) have been used for over 30 years to prevent sudden cardiac death (SCD). The first indications for ICD placement were secondary prevention; later trials demonstrated a primary prevention benefit of ICD therapy in patients at risk of SCD. ICD therapy prolongs life in both patient populations.1 However, the efficacy of an ICD depends on its ability to…
View more
Author(s):
Douglas Packer
Added:
5 years ago
ProfessorDouglas L. Packer discusses the CABANA trial - catheter ablation vs. antiarrhythmic drug therapy for atrial fibrillation.
Filmed on-site at HRS 2018 in Boston, US.
View more
Author(s):
Demosthenes G Katritsis
Added:
3 years ago
The most important papers on arrhythmias and electrophysiology published in 2018, selected by the editors of Arrhythmia and Electrophysiology Review(AER).
Clinical Practice
Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018;1;378:417–27.
Crossref | PubMed
Packer DL, Mark DB, Robb RA, et al. Effect of catheter…
View more
Author(s):
Lisa WM Leung
,
Zaki Akhtar
,
Christos Kontogiannis
,
et al
Added:
1 year ago
Author(s):
Samuel Lévy
Added:
3 years ago
Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice and may be associated with symptoms, haemodynamic impairment and frightening embolic complications. In 1998 recommendations on the management of AF were reported by the Working Group of Arrhythmias of the European Society of Cardiology (ESC). 1 The American College of Cardiology (ACC), the American…
View more
Author(s):
Carina Blomström-Lundqvist
,
Helmut Pürerfellner
,
Alex White
,
et al
Added:
3 years ago
Author(s):
Abhishek Maan
,
Moussa Mansour
,
Jeremy N Ruskin
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice.1 It has been estimated that >3million people in the US and >4.5 million in the EU have paroxysmal or persistent AF.2–4 AF is associated with an approximately fivefold increased risk of stroke,5 threefold risk of heart failure,6 diminished quality of life7 and increased healthcare costs.8,9…
View more
Author(s):
Andrew Grace
,
Hugh Calkins
,
Ken Ellenbogen
,
et al
Added:
3 years ago
Guidelines and Consensus Statements
1. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J 2020;41:655–720. https://doi.org/10.1093/eurheartj/ehz467; PMID:31504425.
2.Cronin EM, Bogun…
View more
Author(s):
George D Katritsis
,
Hugh Calkins
Added:
3 years ago
Over the past decades catheter ablation of atrial fibrillation (AF) has evolved from being a largely experimental procedure to a well-established therapeutic option for certain patients with AF.1–4 Currently the backbone of most catheter ablation techniques is to target the pulmonary veins (PVs) in order to achieve their electrical isolation and maintain sinus rhythm (SR).1 Additional techniques…
View more
Author(s):
Carina Blomström-Lundqvist
,
Jason G Andrade
,
Yassir Javaid
,
et al
Start date:
Feb 24, 2021
View more